Cover Image
市場調查報告書

動物健康的北美市場 (2015∼2019年)

Animal Health Market in North America 2015-2019

出版商 TechNavio (Infiniti Research Ltd.) 商品編碼 342606
出版日期 內容資訊 英文 75 Pages
訂單完成後即時交付
價格
Back to Top
動物健康的北美市場 (2015∼2019年) Animal Health Market in North America 2015-2019
出版日期: 2015年10月21日 內容資訊: 英文 75 Pages
簡介

所謂動物用的醫療活動,是指改善QOL (生活品質) 的和增進壽命,飼養數量的增加等為目的,保護和預防、防止動物得到疾病,提供必要的獸醫服務等。並且,動物用醫療用品中,包含醫藥品 (寄生蟲驅除劑、藥丸等) 和飼料添加物、生技藥品 (生物醫藥品) 等。其中,動物用醫藥品中包含寄生蟲驅除劑和藥丸等。還有飼料添加物提高飼料品質,以增進動物的健康為目的。動物用生技藥品中,包含疫苗和免疫增強劑、過敏原、細菌疫苗、抗體、抗毒素、各種治療藥、類毒素、微生物的抗原性與免疫成分等。北美的動物健康市場2014∼2019年預計以3.75%的年複合成長率(CAGR) 成長。

本報告提供北美各國的動物健康 (動物用醫療用品) 市場相關分析、市場概要和結構、市場規模趨勢 (今後5年的預測值)、動物的各類型/各產品/各國詳細趨勢、推動/阻礙市場要素與其影響力、主要企業簡介、今後的市場機會等調查評估。

第1章 摘要整理

  • 分析結果的概要

第2章 分析範圍

  • 分析概要
  • 大供應商的主要產品

第3章 市場分析技術

  • 分析方法
  • 經濟指標

第4章 簡介

  • 市場趨勢的概要

第5章 市場環境

  • 全球動物健康市場
  • 北美的動物健康市場
  • 波特的五力分析

第6章 動物的各種類的市場區隔

  • 北美的動物健康市場:動物的各種類的區分
  • 家畜市場
  • 寵物市場

第7章 各產品的市場區隔

  • 北美的動物健康市場:各產品的區分
  • 動物用醫藥品市場
  • 動物用生技藥品市場
  • 動物用飼料添加物市場

第8章 地區區分

  • 北美的動物健康市場:各地區的區分
  • 美國市場
  • 加拿大市場

第9章 推動市場要素

第10章 推動因素的影響力

第11章 市場課題

第12章 推動因素、課題的影響力

第13章 市場趨勢

第14章 供應商環境

  • 競爭方案
  • 市場佔有率分析
  • 其他卓越供應商

第15章 其他卓越供應商

  • Biogenesis Bago
  • Boehringer Ingelheim
  • Ceva Sante Animale
  • Heska
  • Lohmann Animal Health International
  • Neogen
  • Novartis
  • Thermo Fisher Scientific (Life Technologies)
  • Vetoquinol
  • Virbac

第16章 主要供應商分析

  • Bayer Animal Health
  • Elanco
  • Merck Animal Health
  • Merial
  • Zoetis

第17章 附錄

  • 簡稱集

第18章 關於Technavio

圖表一覽

目錄
Product Code: IRTNTR7489

About animal health

Animal healthcare involves guarding, preserving, and preventing diseases in animals, and providing necessary veterinary services to enhance their quality of life, increase their lifespan, and increase their yield. Animal healthcare includes pharmaceuticals, feed additives, and biologicals. Animal pharmaceuticals include parasiticides, anti-infectives, tablets, and other pharmaceuticals. Animal medicinal feed additives improve the quality of food for the animal, thereby improving the health of the animal. Animal biologicals include vaccines, immunostimulants, allergens, bacterins, antibodies, antitoxins, diagnostics, toxoids, and antigenic and immunizing components of microorganisms. These products can be natural or synthetic in origin.

Technavio's analysts forecast the animal health market in North America to grow at a CAGR of 3.75% over the period 2014-2019.

Covered in this report

The report covers the current scenario and growth prospects of the animal health market in North America for the period of 2015-2019. To calculate the market size, the report considers revenue generated through sales of various veterinary healthcare products, including:

  • Biologicals
  • Medicinal feed additives
  • Pharmaceuticals

The market is divided into the following segments based on animal type:

  • Commercial animals
  • Companion animals

Technavio's report, Animal Health Market in North America 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers North America; it also covers the landscape of the animal health market in North America and its growth prospects in the coming years. The report also includes a discussion on the key vendors operating in this market.

Key regions

  • Canada
  • US

Key vendors

  • Bayer
  • Elanco
  • Merck
  • Merial
  • Zoetis

Other Prominent Vendors

  • Biogenesis Bago
  • Boehringer Ingelheim
  • Ceva Sante Animale
  • Heska
  • Lohmann Animal Health International
  • Neogen
  • Novartis
  • Thermo Fisher Scientific (Life Technologies)
  • Vetoquinol
  • Virbac

Market driver

  • Increase in consumption of meat and milk
  • For a full, detailed list, view our report

Market challenge

  • Genetic erosion
  • For a full, detailed list, view our report

Market trend

  • Increase in M&A
  • For a full, detailed list, view our report

Key questions answered in this report

  • What will the market size be in 2019 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

Table of Contents

PART 01: Executive summary

  • Highlights

PART 02: Scope of the report

  • Market overview
  • Top-vendor offerings

PART 03: Market research methodology

  • Research methodology
  • Economic indicators

PART 04: Introduction

  • Key market highlights

PART 05: Market landscape

  • Global animal health market
  • Animal health market in North America
  • Five forces analysis

PART 06: Market segmentation by animal type

  • Market segmentation by animal type
  • Commercial animal health market in North America
  • Companion animal health market in North America

PART 07: Market segmentation by product

  • Segmentation of animal health market in North America by product
  • Animal pharmaceuticals market in North America
  • Animal biologicals market in North America
  • Animal medicinal feed additives market in North America

PART 08: Geographical segmentation

  • Segmentation of animal health market in North America by geography
  • Animal health market in US
  • Animal health market in Canada

PART 09: Market drivers

PART 10: Impact of drivers

PART 11: Market challenges

PART 12: Impact of drivers and challenges

PART 13: Market trends

PART 14: Vendor landscape

  • Competitive scenario
  • Market share analysis
  • Other prominent vendors

PART 15: Other prominent vendors

  • Biogenesis Bago
  • Boehringer Ingelheim
  • Ceva Sante Animale
  • Heska
  • Lohmann Animal Health International
  • Neogen
  • Novartis
  • Thermo Fisher Scientific (Life Technologies)
  • Vetoquinol
  • Virbac

PART 16: Key vendor analysis

  • Bayer Animal Health
  • Elanco
  • Merck Animal Health
  • Merial
  • Zoetis

PART 17: Appendix

  • List of abbreviations

PART 18: Explore Technavio

List of Exhibits

  • Exhibit 01: Product offerings
  • Exhibit 02: Global animal health market 2014-2019 ($ billions)
  • Exhibit 03: Animal health market in North America 2014-2019 ($ billions)
  • Exhibit 04: Five forces analysis
  • Exhibit 05: Segmentation of animal health market in North America by animal type 2014
  • Exhibit 06: Segmentation of animal health market in North America by animal type 2019
  • Exhibit 07: Segmentation of animal health market in North America by animal type 2014-2019 ($ billions)
  • Exhibit 08: Segmentation of animal health market in North America by animal type 2014-2019
  • Exhibit 09: Commercial animal health market in North America 2014-2019 ($ billions)
  • Exhibit 10: Projected growth in consumption of selected animal types in North America
  • Exhibit 11: Companion animal health market in North America 2014-2019 ($ billions)
  • Exhibit 12: Segmentation of animal health market in North America by product 2014
  • Exhibit 13: Segmentation of animal health market in North America by product 2019
  • Exhibit 14: Segmentation of animal health market in North America by product 2014-2019 ($ billions)
  • Exhibit 15: Segmentation of animal health market in North America by product 2014-2019
  • Exhibit 16: Animal pharmaceuticals market in North America 2014-2019 ($ billions)
  • Exhibit 17: Animal biologicals market in North America 2014-2019 ($ billions)
  • Exhibit 18: Animal medicinal feed additives market in North America 2014-2019 ($ billions)
  • Exhibit 19: Segmentation of animal health market in North America by geography 2014-2019
  • Exhibit 20: Segmentation of animal health market in North America by geography 2014-2019 ($ billions)
  • Exhibit 21: Animal health market in US 2014-2019 ($ billions)
  • Exhibit 22: Animal health market in Canada 2014-2019 ($ billions)
  • Exhibit 23: US population 2009-2014 (millions)
  • Exhibit 24: Impact of drivers
  • Exhibit 25: Impact of drivers and challenges
  • Exhibit 26: Elanco: Geographical segmentation by revenue 2014
  • Exhibit 27: Merck: Business segmentation by revenue 2013 and 2014 ($ millions)
  • Exhibit 28: Merck: Revenue by geography 2014
  • Exhibit 29: Zoetis: Business segmentation by revenue 2014
  • Exhibit 30: Zoetis: Product segmentation by revenue 2014
  • Exhibit 31: Zoetis: Business segmentation by revenue 2013 and 2014 ($ millions)
Back to Top